85
Views
11
CrossRef citations to date
0
Altmetric
Letters to the Editor

Complete remission induced by thalidomide in a case of angioimmunoblastic T-cell lymphoma refractory to autologous stem cell transplantation

, , , , , , & show all
Pages 1836-1838 | Received 18 Apr 2008, Accepted 23 May 2008, Published online: 01 Jul 2009

References

  • Gisselbrecht C, Gaulard P, Lapage E, Coiffier B, Brière J, Haioun C, et al. Prognostic significance of T-cell phenotype in aggressive non-Hodgkin's lymphomas. Groupe d'Etudes des Lymphomes de l'Adulte (GELA). Blood 1998; 92: 76–82
  • Schetelig J, Fetscher S, Reichle A, Berdel W E, Bequin Y, Brunet S, et al. Long-term disease-free survival in patients with angioimmunoblastic T-cell lymphoma after high-dose chemotherapy and autologous stem cell transplantation. Haematologica 2003; 88: 1272–1278
  • Rodrìguez J, Conde E, Gutìerrez A, Arranz R, Gandarillas M, Leon A, et al. Prolonged survival of patients with angioimmunoblastic T-cell lymphoma after high-dose chemotherapy and autologous stem cell transplantation: the GELTAMO experience. Eur J Haematol 2007; 78: 290–296
  • Advani R, Warnke R, Sikic B I, Horning S. Treatment of angioimmunoblastic T-cell lymphoma with cyclosporine. Ann Oncol 1997; 8: 601–603
  • Strupp C, Aivado M, Germing U, Gattermann N, Haas R. Angioimmunoblastic lymphadenopathy (AILD) may respond to thalidomide treatment: two case reports. Leuk Lymphoma 2003; 43: 133–137
  • Dogan A, Ngu L S, Ng S H, Cervi P L. Pathology and clinical features of angioimmunoblastic T-cell lymphoma after successful treatment with thalidomide. Leukemia 2005; 19: 873–875
  • Damaj G, Bouabdallah R, Vey N, Bilger K, Mohty M, Gastaut J A. Single-agent thalidomide induces response in T-cell lymphoma. Eur J Haematol 2005; 74: 169–171
  • Ramasamy K, Lim Z, Pagliuca A, Salisbury J R, Mufti G J, Devereux S. Successful treatment of angioimmunoblastic T-cell lymphoma with thalidomide and dexamethasone. Haematologica 2006; 91: S26–S27
  • Kyriakou C, Canals C, Goldstone A, Caballero D, Metzner B, Kobbe G, et al. High-dose therapy and autologous stem-cell transplantation in angioimmunoblastic lymphoma: complete remission at transplantation is the major determinant of Outcome-Lymphoma Working Party of the European Group for Blood and Marrow Transplantation. J Clin Oncol 2008; 26: 218–224

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.